MANAGEMENT'S DISCUSSION AND
ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
THE
FOLLOWING INFORMATION SHOULD BE READ IN CONJUNCTION WITH THE CONSOLIDATED FINANCIAL
STATEMENTS OF EYI AND THE NOTES THERETO APPEARING ELSEWHERE IN THIS FILING.
STATEMENTS IN THIS MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
AND ELSEWHERE IN THIS PROSPECTUS THAT ARE NOT STATEMENTS OF HISTORICAL OR CURRENT
FACT CONSTITUTE "FORWARD-LOOKING STATEMENTS."
Overview
We
are in the business of selling, marketing, and distributing a product line consisting
of approximately 34 nutritional products in two categories, dietary supplements
and personal care products. Our most successful product is Calorad, a liquid
collagen-based dietary supplement presently available on the market. These products
are marketed through a network marketing program in which IBAs (Independent
Business Associates) purchase products for resale to retail customers as well
as for their own personal use. We have a list of over 400,000 IBAs, of which
approximately 11,000 we consider "active". An "active" IBA is one who purchased
our products within the preceding 12 months. Over 1,600 of these IBAs are "very
active", and are on our automatic Auto-ship Program.
The
IBAs in our network are encouraged to recruit interested people to become new
distributors of our products. New IBAs are placed beneath the recruiting IBA
in the "network" and are referred to as being in that IBA's "down-line" organization.
Our marketing plan is designed to provide incentives for IBAs to build, maintain
and motivate an organization of recruited distributors in their down-line organization
to maximize their earning potential. IBAs generate income by purchasing our
products at wholesale prices and reselling them at retail prices. IBAs also
earn commissions on product purchases generated by their down-line organization.
On
an ongoing basis we review our product line for duplication and sales trends
and make adjustments accordingly. As of June 30, 2004, our product line consisted
of: (i) 23 dietary supplement products; and (ii) 11 personal care products consisting
primarily of cosmetic and skin care products. Our products are primarily manufactured
by Nutri-Diem, Inc., a related party, and sold by us under a license and distribution
agreement with Nutri-Diem Inc. Certain of our own products are manufactured
for us by third party manufacturers pursuant to formulations developed for us.
Our products are sold to our IBAs located in all 50 states, the District of
Columbia and Canada.
We
believe that our network marketing system is suited to marketing dietary supplement
and personal care products, because sales of such products are strengthened
by ongoing personal contact between IBAs and their customers. Our network marketing
system appeals to a broad cross-section of people, particularly those looking
to supplement family income or who are seeking part-time work. IBAs are given
the opportunity, through our sponsored events and training sessions, to network
with other distributors, develop selling skills and establish personal goals.
We supplement monetary incentives with other forms of recognition, in order
to motivate IBAs.
Recent Corporate Developments
In
July, 2004 we entered into a letter of intent with a private Canadian company
for the purpose of acquiring all of its assets (the "Assets") including a worldwide
marketing and distribution license of certain products manufactured by Kawahara
Co. Ltd. Of Japan. The letter of intent is subject to the consummation of a
definitive agreement between the parties by November 1, 2004, and the completion
of our due diligence review of the company's Assets. The purchase price for
the Assets will be mutually agreed upon, upon completion of our due diligence
inspections.
During
the quarter ended June 30, 2004, we constructed and completed our first video-streaming
ads and developed a Calorad customer training series of video-streams. We are
prepared to share this video-streaming training model with our core Network
channel. Additionally, both EyeWonder, Inc. and our internet web-marketing division
have begun to test the ads in real time. In the next phase we intend to commence
a sales initiative to capture sales, create brand awareness and support sales
campaigns.
On
May 4, 2004 we entered into a letter agreement with Eyewonder, Inc., pursuant
to which Eyewonder agreed to manage an advertising and lead generation campaign
to promote and sell our products utilizing Eyewonder's proprietary
26
audio-video streaming technology. In consideration of the
services provided by Eyewonder under the agreement, we agreed to pay the following
fees: a fee of $100,000 for product promotions, a fee of $770,000 for the implementation
of a communications component for the campaign, and a fee of $140,000 for each
consumer application. Under the terms of the agreement we have the option to
pay fees to Eyewonder through the issuance to Eyewonder of units of our stock,
each consisting one share at a price of $0.21 per share and one share purchase
warrant exercisable at a price of $0.30 per share for a period of five years
from the date of issuance. Eyewonder is also entitled to a fee of 8% of the
gross revenue generated through all sales of products that result from responses
to advertising by Eyewonder. In addition, on execution of the agreement, we
agreed to issue options to purchase 1,100,000 shares of our common stock at
a price of $0.22 per share to certain individuals designated by Eyewonder.
On
April 30, 2004 we entered into an amendment to our License and Distribution
Agreement with Nutri-Diem, lowering the amount of expenditures we are required
to make under the agreement. Pursuant to the terms of the amendment to the License
and Distribution Agreement we are presently required to expend the following
amounts on purchasing the products of Nutri-Diem over the term of the License
and Distribution Agreement: (i) from June 1, 2003 to May 31, 2004, $1,530,000,
from June 1, 2004 to May 31, 2005, $3,825,000, and (iii) for each year thereafter,
$5,355,000.
Our
core business is in network marketing development and sales. In 2004 we implemented
some critical changes to our network marketing development and sales strategy.
We analyzed our compensation structure and realized that although the plan paid
the sales force more than industry standard, it was still not encouraging sales,
growth, duplication or retention. After months of study, outside consulting,
field leader's focus groups and senior management discussion, we made key adjustments
during our first fiscal quarter in 2004 that are intended to cap the sales commission
expense while at the same time promote increased network sales. We anticipate
retaining a higher percentage of both customers and distributors with this new
plan.
To
further facilitate growth and benefit from certain competitive advantages conferred
by the new commission plan, we have upgraded our Internet support sites, created
a trainer field certification program, developed a regional training program
and increased our face to face training capability. These support tools are
intended to ensure compliance, mature team and territory development and assist
sales growth.
We
see international sales as a key component for our growth in the next 5 years.
During our second quarter of fiscal 2004, we entered into a joint venture agreement
with World Wide Buyers' Club Inc. and Supra Group, Inc., dated as of May 28,
2004, for the purpose of jointly marketing and distributing our products through
the existing Supra Group distribution system in the Latin American countries
identified in the Joint Venture Agreement and the products of Supra Group using
the existing EYI distribution system to residents in the U.S. We believe Supra
Group has significant international experience, expertise and contacts and that
this alliance will assist in our ability to expand into Spanish-speaking countries.
We
also distribute our products through brick and mortar retail stores. We encourage
and support our IBA's in placing our nutritional supplements in retail environments
that include doctor's offices, spas, gyms, health food stores and pharmacies.
We have recently upgraded our merchandising tools and believe that there is
potential in continuing and expanding these sales.
Our
plan of operations over the next twelve months is to undertake the following:
1.
We
plan to expand the marketing of our Calorad product over the next twelve months.
We feel that our main product Calorad, a 21 year old market proven product,
is positioned to expand into the weight loss industry.
2.
We
intend to upgrade our computer systems over the next twelve months. These upgrades
are intended to result in improved operational efficiency with the objective
of reducing overhead costs.
Critical Accounting Policies
The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States requires our management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting
periods. Actual results may differ from those estimates.
Our
management routinely makes judgments and estimates about the effects of matters
that are inherently uncertain. As the number of variables and assumptions affecting
the probable future resolution of the uncertainties increase, these
27
judgments become even more subjective and complex. We have
identified certain accounting policies, described below, that are the most important
to the portrayal of our current financial condition and results of operations.
Accounts Receivable and Bad Debts
EYI
Industries estimates bad debts utilizing the allowance method, based upon past
experience and current market conditions. At December 31, 2003 and June 30,
2004, EYI determined that no allowance was required, as most sales are transacted
via credit card or electronic transfer and therefore are considered immediately
collectible.
Cash and Cash Equivalents
For
purposes of the statement of cash flows, EYI Industries considers all highly
liquid investments and short-term debt instruments with original maturities
of three months or less to be cash equivalents.
Restricted Cash
Restricted
cash includes deposits held in a reserve account in the amount of $223,682 at
December 31, 2003 and in the amount of $210,314 at June 30,2004. Such deposits
are required by the bank as protection against unfunded charge backs and returns
of credit card transactions.
Compensated Absences
Employees
of EYI Industries are entitled to paid vacation, and sick days, depending on
job classification, length of service, and other factors. EYI Industries accrued
vacation pay in the amounts of $38,000 and $59,000 at December 31, 2003 and
June 30, 2004, respectively.
Cost of Sales
Cost
of sales consist of the purchase price of products sold, commissions, inbound
shipping charges, net of freight recovered from customers, and packaging supplies.
Derivative Instruments
The
Financial Accounting Standards Board issued Statement of Financial Accounting
Standards No. 133, "Accounting for Derivative Instruments and Hedging Activities"
(hereinafter "SFAS No. 133"), as amended by SFAS No. 137, "Accounting for Derivative
Instruments and Hedging Activities Deferral of the Effective Date of
FASB No. 133", and SFAS No. 138, "Accounting for Certain Derivative Instruments
and Certain Hedging Activities", and SFAS No. 149, "Amendment of Statement 133
on Derivative Instruments and Hedging Activities". These statements establish
accounting and reporting standards for derivative instruments, including certain
derivative instruments embedded in other contracts, and for hedging activities.
They require that an entity recognize all derivatives as either assets or liabilities
in the balance sheet and measure those instruments at fair value.
If
certain conditions are met, a derivative may be specifically designated as a
hedge, the objective of which is to match the timing of gain or loss recognition
on the hedging derivative with the recognition of (i) the changes in the fair
value of the hedged asset or liability that are attributable to the hedged risk
or (ii) the earnings effect of the hedged forecasted transaction. For a derivative
not designated as a hedging instrument, the gain or loss is recognized in income
in the period of change.
At
December 31, 2003 and June 30, 2004, EYI Industries has not engaged in any transactions
that would be considered derivative instruments or hedging activities.
28
Earnings Per Share
EYI
Industries has adopted Statement of Financial Accounting Standards No. 128,
which provides for calculation of "basic" and "diluted" earnings per share.
Basic earnings per share includes no dilution and is computed by dividing net
income (loss) available to common shareholders by the weighted average common
shares outstanding for the period. Diluted earnings per share reflect the potential
dilution of securities that could share in the earnings of an entity similar
to fully diluted earnings per share. Basic and diluted loss per share were the
same, at the reporting dates, as there were no common stock equivalents outstanding.
Fair Value of Financial Instruments
EYI
Industries' financial instruments as defined by Statement of Financial Accounting
Standards No. 107, "Disclosures about Fair Value of Financial Instruments,"
include cash, trade accounts receivable, and accounts payable and accrued expenses.
All instruments are accounted for on a historical cost basis, which, due to
the short maturity of these financial instruments, approximates fair value at
December 31, 2003 and June 30, 2004.
Foreign Currency Translation and Other Comprehensive Income
EYI
Industries has adopted Financial Accounting Standard No. 52. Monetary assets
and liabilities denominated in foreign currencies are translated into United
States dollars at rates of exchange in effect at the balance sheet date. Gains
or losses are included in income for the year. Non-monetary assets, liabilities
and items recorded in income arising from transactions denominated in foreign
currencies are translated at rates of exchange in effect at the date of the
transaction.
As
EYI Industries' functional currency is the U.S. dollar, and all translation
gains and losses are transactional, EYI Industries has no assets with value
recorded in Canadian dollar and there is no recognition of other comprehensive
income in the financial statements.
Foreign Currency Valuation and Risk Exposure
While
EYI Industries' functional currency is the U.S. dollar and the majority of its
operations are in the United States, EYI Industries maintains its main operations
office in Surrey, British Columbia. The assets and liabilities relating to the
Canadian operations are exposed to exchange rate fluctuations. Assets and liabilities
of EYI Industries' foreign operations are translated into U.S. dollars at the
year-end exchange rates, and revenue and expenses are translated at the average
exchange rate during the period. The net effect of exchange difference arising
from currency translation is disclosed as a separate component of stockholders'
equity. Realized gains and losses from foreign currency transactions are reflected
in the results of operations.
Income Taxes
EYI
Industries accounts for income taxes under the provisions of Statement of Financial
Accounting Standards No. 109, "Accounting for Income Taxes". This statement
requires the recognition of deferred tax liabilities and assets for the future
consequences of events that have been recognized in EYI Industries consolidated
financial statement or tax returns. Measurement of the deferred items is based
on enacted tax laws. In the event the future consequences of differences between
financial reporting bases and tax bases of EYI Industries assets and liabilities
results in a deferred tax asset, SFAS No. 109 requires an evaluation of the
probability of being able to realize the future benefits indicated by such an
asset. A valuation allowance related to a deferred tax asset is recorded when
it is more likely than not that some portion or all of the deferred tax asset
will not be realized.
Inventories
EYI
Industries records inventories at the lower of cost or market on a first-in,
first-out basis.
29
Long-lived Assets
In
accordance with Statement of Financial Accounting Standards No. 144, "Accounting
for the Impairment or Disposal of Long-Lived Assets". This standard establishes
a single accounting model for long-lived assets to be disposed of by sale, including
discontinued operations, and requires that these long-lived assets be measured
at the lower of carrying amount or fair value less cost to sell, whether reported
in continuing operations or discontinued operations. Accordingly, EYI Industries
reviews the carrying amount of long-lived assets for impairment where events
or changes in circumstances indicate that the carrying amount may not be recoverable.
The determination of any impairment would include a comparison of estimated
future cash flows anticipated to be generated during the remaining life of the
assets to the net carrying value of the assets. For the years ended December
31, 2003 and June 30, 2004, no impairments have been identified.
Property and Equipment
Property
and equipment are stated at cost. Depreciation of property and equipment is
calculated using the straight-line method over the estimated useful lives of
the assets, which range from three to seven years.
Principles of Consolidation
The
consolidated financial statements include the accounts of EYI Industries and
its wholly owned subsidiaries. All significant transactions and balances among
the companies included in the consolidated financial statements have been eliminated.
Revenue Recognition
EYI
Industries recognizes revenue from product sales upon shipment to independent
distributors, EYI Industries' customers. Revenue from administration fees is
recognized upon collection from independent distributors.
Use of Estimates
The
process of preparing financial statements in conformity with accounting principles
generally accepted in the United States of America requires the use of estimates
and assumptions regarding certain types of assets, liabilities, revenues, and
expenses. Such estimates primarily relate to unsettled transactions and events
as of the date of the financial statements. Accordingly, upon settlement, actual
results may differ from estimated amounts.
Segment Information
EYI
Industries adopted Statement of Financial Accounting Standards No. 131, "Disclosures
about Segments of an Enterprise and Related Information," (hereafter "SFAS No.
131") which supersedes SFAS No. 14, "Financial Reporting for Segments of a Business
Enterprise," replacing the "industry segment" approach with the "management"
approach. The management approach designates the internal organization that
is used by management for making operating decisions and assessing performance
as the source of EYI Industries reportable segments. SFAS No. 131 also requires
disclosures about products and services, geographic areas and major customers.
The adoption of SFAS No. 131 did not affect EYI Industries results of operations
or financial position.
Recent Accounting Pronouncements
New
accounting pronouncements that have a current or future potential impact on
our financial statements are as follows:
In
May 2003, the Financial Account Standards Board issued Statement of Financial
Accounting Standards No. 150, "Accounting for Certain Financial Instruments
with Characteristics of Both Liabilities and Equity" (hereinafter "SFAS No.
150"). SFAS No. 150 establishes standards for classifying and measuring certain
financial instruments with characteristics of both liabilities and equity and
requires that those instruments be classified as liabilities in statements of
financial position. Previously, many of those instruments were classified as
equity. SFAS No. 150 is effective for financial instruments entered
30
into or modified after May 31, 2003 and otherwise is effective
at the beginning of the first interim period beginning after June 15, 2003.
We have determined that there was no impact on us from the adoption of the statement.
Results Of Operations
Results
Of Operations For The Three And Six Month Periods Ended June 30, 2004, As Compared
To The Three And Six Month Periods Ended June 30, 2003.
Net
Sales
Net
sales for six months ended June 30, 2004 was $3,494,932, compared to net sales
of $6,974,710 during the comparative period in 2003. This represents a decline
of $3,479,778 or 49.9% . Net sales for the three months ended June 30, 2004
were $1,965,737 compared to net sales of $2,775,506 during the comparative period
in 2003, representing a decrease of $809,769 or 29.2% . The decrease in our
net sales during the period ended June 30, 2004 was primarily the result of
adjustments to our sales commission plan for our independent business associates
("IBAs") implemented during our first fiscal quarter in 2004 that were intended
to cap the sales commission expenses.
For
the six months ended June 30, 2004, the cost of goods sold was $2,176,014 compared
to $4,761,924 for the comparative period in 2003. This represents a decline
of $2,585,910 or 54.3% . For the three months ended June 30, 2004, the cost
of goods sold was $1,343,919 compared to $1,750,595 for the comparative period
in 2003, representing a decrease of $406,676 or 23.2% . The decline in cost
of goods sold during the period ended June 30, 2004 is attributed to the implementation
of our new compensation plan for our IBAs.
Operating
Expenses
Our
operating expenses decreased to $2,474,327 during the six months ended June
30, 2004 compared to operating expenses of $3,000,261 as at June 30, 2003. Our
operating expenses during the three months ended June 30, 2004 increased to
$1,370,449 compared to operating expenses of $1,225,136 during the three months
ended June 30, 2003, representing an increase of $145,313 or 11.9%. The increase
of our operating expenses during the period ended June 30, 2004 was primarily
due to the increased telecommunications and advertising expenditures. Our operating
expenses consist principally of salaries and other personnel costs for our administrative
staff, rent, legal and professional fees, consulting fees, sales and marketing
expenses and warehouse expenses.
Compensation
Expense
For
the six months ended June 30, 2004, compensation expense was $559,714 compared
to $567,458 for the six months ended June 30, 2003. The increase in our compensation
expense during the period is attributed to the hiring of additional customer
service staff.
Net
Loss
Our
net loss for the six months ended June 30, 2004 increased to $1,110,249 from
a net loss of $809,811 for the comparative period in 2003. Our net loss for
the three months ended June 30, 2004 increased to $734,964 from a net loss of
$188,665 during the same period in 2003, representing an increase of $546,299
or 289%. The increased net loss for the period ended June 30, 2004 is primarily
attributed to the decline in gross profit and increases to advertising and telecommunication
expenses.
Results
of Operations For The Six Month Period Ended December 31, 2003 As Compared To
The Twelve Month Period Ended June 30, 2003
During
the six-month period ended December 31, 2003 we had total revenues of $4,313,579
and gross profits of $1,467,779 compared to revenues of $14,390,049 and gross
profits of $3,878,343 during the year ended June 30, 2003.
31
We
incurred operating expenses in the amount of $2,446,108 for the six months ended
December 31, 2003, compared to $5,523,775 for the year ended June 30, 2003.
Our operating expenses consist principally of salaries and other personnel costs
for our administrative staff, rent, legal and professional fees, consulting
fees, sales and marketing expenses and warehouse expenses. As a percentage of
revenues, operating expenses increased from 38.3% during the year ended June
30, 2003 to 56.7% during the six months ended December 31, 2003, primarily as
a result of lower revenues.
We
incurred professional fees in the amount of $145,001 during the six months ended
December 31, 2003, compared to $354,356 for the year ended June 30, 2003. These
professional fees were primarily attributable to our filing a registration statement
under the Securities Act of 1933, the reorganization of our company and our
becoming reporting company under the Securities Exchange Act of 1934.
Net
Loss
We
incurred a loss before other items of $969,987 for the six months ended December
31, 2003, compared to a loss before other items of $1,644,456 for the year ended
June 30, 2003. Our loss before other items was attributable entirely to operating
expenses.
Liquidity And Capital Resources
Cash And Working Capital
We
had cash of $60,524 as at June 30, 2004, compared with cash of $52,075 as at
December 31, 2003. Our working capital deficit decreased to $15,227 as at June
30, 2004, compared to a working capital deficit of $1,265,833 as at December
31, 2003. The decrease in our working capital deficit was primarily attributed
to our agreement with Eyewonder during the quarter, pursuant to which we prepaid
$770,000 towards the communications component of the agreement.
Liabilities
The
largest component of our working capital deficit are accounts payable and accrued
liabilities in the amount of $1,359,625 as at June 30, 2004 including amounts
payable to related parties, compared to $1,616,118 as at December 31, 2003.
Cash
Used in Operating Activities
Cash
used in operating activities for the six months ended June 30, 2004 was $475,306
compared to $605,346 for the comparative period in 2003, representing a decrease
of $130,040 or 21%.
Cash
Provided By Financing Activities
We
have continued to finance our business primarily through private placement sales
of our common stock, exercises of stock options, short term loans, conversion
of accrued liabilities into stock and through increases in our accrued liabilities
and accounts payable. Cash provided by financing activities for the six months
ended June 30, 2004 was $470,387, compared to $51,704 for the six months ended
June 30, 2003.
Financing
activities included the issuance of common stock for aggregate proceeds of $470,387
during the six months ended June 30, 2004 in private placement and other financing
transactions. The private placement transactions
32
included the issue of an aggregate of 566,833 shares of our
common stock and associated share purchase warrants, representing an average
price of $0.25 per share. During the three months ended June 30, 2004 we issued
4,200,000 and 300,000 shares upon exercise of options with an exercise price
of $0.165 per share and $0.20 per share, respectively. All shares issued pursuant
to stock option exercises during our first quarter were registered on Form S-8
registration statements that we filed with the SEC. During the three months
ended June 30, 2004 we made the following issuances: 50,000 restricted shares
of our common stock at a price of $0.22 per share in payment of consulting fees
to a consultant; 1,266,589 restricted shares of our common stock to Cornell
in payment of certain fees owed to Cornell under the terms of the Standby Equity
Agreement; and 33,411 restricted shares of our common stock to Newbridge under
the terms of the Placement Agent Agreement. During the three months ended June
30, 2004 we issued 5,476,190 restricted shares of our common stock to Eyewonder,
Inc. in payment of fees. During the six months ended June 30, 2004 we issued
350,000 restricted shares of our common stock at a price of $0.28 per share
in payment of consulting fees to two consultants.On June 22, 2004, we issued
a secured convertible debenture to Cornell Capital Partners in the principal
amount of $250,000. The secured convertible debentures are convertible at the
holder’s option any time up to maturity at a conversion price equal to
the lower of (i) 120% of the closing bid price of the common stock as of the
date of issuance, or (ii) 80% of the average of the lowest daily volume weighted
average price of our common stock for the 5 trading days immediately preceding
the conversion date. At maturity, the remaining unpaid principal and accrued
interest under the debentures shall be, at our option, either paid or converted
into shares of common stock at a conversion price equal to the lower of (i)
120% of the closing bid price of the common stock as of the date of issuance
or (ii) 80% of the lowest closing bid price of the common stock for the lowest
trading days of the 5 trading days immediately preceding the conversion date.
The secured convertible debenture is secured by all of EYI Industries’
assets. The secured convertible debentures accrues interest at a rate of 5%
per year and has a term of 3 years. In the event the secured convertible debentures
are redeemed, then EYI Industries will issue to Cornell Capital Partners a warrant
to purchase 50,000 shares for every $100,000 redeemed at an exercise price of
120% of the closing bid price as of June 22, 2004. Cornell Capital Partners
purchased the secured convertible debentures from EYI Industries in a private
placement on June 22, 2004. EYI Industries is registering in this offering 8,352,823
shares of common stock underlying the secured convertible debentures. EYI Industries
received $250,000 from the issuance of the first secured convertible debenture
on June 22, 2004, and we will receive $250,000 5 business days following the
filing of the accompanying registration statement.
Financing Requirements
We
currently have minimal cash and working capital resources. We do not have adequate
financial resources in order to enable us to continue our business operations
without additional financing. Our current sources of working capital are sufficient
to satisfy our anticipated working capital needs for approximately the next
twenty-two weeks. As of August 24, 2004, we estimate that we will require $1,800,000
to fund our operating expenses for the next twelve months. We may not be able
to obtain additional working capital on acceptable terms, or at all. Accordingly,
there is substantial doubt about our ability to continue as a going concern.
We
will require additional financing if we are to continue as a going concern and
to finance our business operations. We anticipate that any additional financing
would be through the sales of our common or preferred stock or placement of
convertible debt. We are presently in the process of negotiating private placements
of our securities to raise working capital to finance our operations. However,
we do not have any arrangements in place for the sale of any of our securities
and there is no assurance that we will be able to raise the additional capital
that we require to continue operations. In the event that we are unable to raise
additional financing on acceptable terms, then we may have to scale back our
plan of operations and operating expenditures. We anticipate that we will continue
to incur losses until such time as the revenues we are able to generate from
sales and licensing of our products exceed our increased operating expenses.
We base this expectation in part on the expectation that we will incur increased
operating expenses in completing our stated plan of operations and there is
no assurance that we will generate revenues that exceed these expenses.
On
June 22, 2004, we entered into a Standby Equity Distribution Agreement with
Cornell Capital Partners. Pursuant to the Standby Equity Distribution Agreement,
we may, at our discretion, periodically issue and sell shares of our common
stock for a total purchase price of $10 million. If we request advances under
the Standby Equity Distribution Agreement, Cornell Capital partners will purchase
shares of common stock of EYI Industries for 98% of the lowest volume weighted
average price on the Over-the-Counter Bulletin Board or other principal market
on which our common stock is traded for the 5 days immediately following the
advance notice date. Cornell Capital Partners will retain 5% of each advance
under the Standby Equity Distribution Agreement. We may not request advances
in excess of a total of $10 million. The maximum of each advance is equal to
$250,000.
33